XML 60 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Share capital, share premium and other capital reserves (Tables)
12 Months Ended
Dec. 31, 2022
Share capital, share premium and other capital reserves  
Schedule of share capital

The following table provides information about the Company’s share capital as of December 31, 2022, 2021 and 2020:

(in thousands, except

Authorized

Issued and fully paid

Additional paid-in capital

Share premium

for share and per

December 31, 

December 31, 

December 31, 

December 31, 

share amounts)

  

2022

  

2021

  

2020

  

2022

  

2021

  

2020

  

2022

  

2021

  

2020

Common shares of $0.01 each

 

447,525

 

 

 

281,775

 

$

 

$

$

Preference Series A shares of $0.01 each

 

1,755,845

 

 

 

1,037,595

 

 

722

Preference Series B shares of $0.01 each

 

3,899,766

 

 

 

3,899,766

 

 

18,340

Preference Series C shares of $0.01 each

 

4,133,805

 

 

 

4,133,805

 

 

22,026

Preference shares of $0.01 each

 

9,789,416

 

 

 

9,071,166

41,088

Preference shares of $0.14 each

45,000,000

45,000,000

Common shares of $0.14 each

45,000,000

45,000,000

26,289,087

25,775,538

194,424

192,270

90,000,000

 

90,000,000

10,236,941

 

26,289,087

 

25,775,538

9,352,941

$

194,424

$

192,270

$

41,088

Schedule of major shareholders on a non-diluted basis

As of December 31, 

    

2022

    

2021

 

Gilde Healthcare

 

20.6

%  

21.0

%

Versant Venture Capital VI, L.P.

 

17.5

%  

17.8

%

Novo Holdings A/S

 

12.7

%  

12.9

%

Redmile Biopharma Investments

 

10.6

%  

10.8

%

Sanofi Foreign Participations B.V.

 

7.3

%  

7.4

%

Ysios Capital Partners, SGECR,S.A.U.

 

%  

6.2

%

Other shareholders

 

31.3

%  

23.9

%

 

100.0

%  

100.0

%